Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
More Vaping-Related Dangers?
According to a recent Yale study, inhaling vapor from flavored e-cigarette liquid exposes users to previously undetected chemical byproducts called acetals. As a result of the study, the authors hope the FDA will begin to study the short- and long-term effects of inhaled acetals.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
Subspecialties Collaborate on New Program to Train Minorities in Addiction Psychiatry and Addiction Medicine
The medical subspecialties of addiction psychiatry and addiction medicine are collaborating with the Yale Department of Psychiatry on a new program to help train minorities and expand their presence in the two subspecialties.
Delphin-Rittmon to Remain Commissioner of DMHAS in Lamont Administration
Miriam E. Delphin-Rittmon, PhD, Associate Professor of Psychiatry at Yale School Medicine, will remain Commissioner of the Connecticut Department of Mental Health and Addiction Services (DMHAS) under the new administration of Governor Ned Lamont.